Abstract: A short and efficient synthesis of enantiomerically pure α-hydroxylated lactone lignans starting from commercially available diisopropyl malate is presented. Stereoselective alkylation with various benzyl bromides and saponification yielded the corresponding succinic acids. Acetalization afforded the dioxolanones, which were stereoselectively alkylated. Reduction (and deprotection, where required) yielded the lactone lignans in up to 30 % overall yield. The inhibition of the proliferation of HT29 colon cancer cells was investigated. One lignane, bis-2,4,6-trimethylbenzyllactone lignan, was active (IC 50 = 35 µM), whereas all other tested lignans were inactive within the investigated concentration range.
INTRODUCTION
Lactone lignans are important secondary plant metabolites possessing a variety of biological activities [1, 2] . A prominent derivative is (-)-matairesinol (1) [2] . It is widely accepted that 1 (Scheme 1) acts as phytoestrogen and competitive binder to the corresponding estrogen receptor [3] . Matairesinol (1) is metabolized in the gastrointestinal tract to rac-enterolactone (2) [4, 5] . It is believed that lignans 1 and/or 2 have an inhibitory effect on hormone-dependent cancer [3] .
liminary evaluation of their biological activity against HT29 cancer cells. The compounds were obtained in 5-6 steps from dialkyl malates 4 and in overall yields of up to 30 %.
The initial step of the synthesis was the diastereoselective alkylation of dialkyl malates, a reaction that has been used frequently in the past [16] . However, according to the standard procedure [12b] (base, then dialkyl malate, then -78 → -20 °C for 2 h, then -78 °C, then electrophile, then -78 → 0 °C, 15-20 h), the alkylation of dimethyl malate (5) with benzyl bromide 6 proceeded in only 20 % to afford 8 and 9 in 89:11 diastereoselectivity (Scheme 3). A survey of the literature revealed that this procedure was never changed significantly. Furthermore, average yields of about 50-60 % with diastereoselectivities in the range of 9:1 anti/syn have been reported [16] . A major problem encountered in this procedure is the complete enolization of the malate before addition of the electrophile because the second carboxy group contained in dialkyl malates can act as an electrophile, affording ester condensation products [17] . We found that the alkylation can be carried out with improved yield (75 %) when ester 5, benzyl bromide 6, and lithium hexamethyldisilazide (LHMDS) are mixed together at -78 °C, and the reaction mixture is warmed to 10 °C [14, 15] . This procedure for the α-alkylation of esters (addition of the base in the presence of the electrophile) is uncommon with metal bases, but is used frequently when highly reactive neutral P-bases are employed [18] .
Yield and diastereoselectivity of the α-alkylation of dialkyl malates are not only dependent on the procedure followed, but also on the two alkylester groups involved [19] . We found that the highest yields were obtained with a t Bu group at C4 (90-94 %), although the diastereoselectivity decreased from 89:11 to 82:18-84:16. On the other hand, the maximum diastereoselectivity was obtained with an i Pr group at C4 and a t Bu group at C1 > 97:3, but the product was attained in only 78 % yield. The best compromise with respect to reactivity and availability of the starting material was the use of diisopropyl malate [19] . This malic acid ester is easy to prepare, and its alkylation with various benzyl bromides was achieved with good yields and high stereoselectivities (~95:5, 9-11). An exception to these results was the 2,4,6-trimethylbenzyl substituted malate 12, which was obtained in a d.r. of 83:17 (Scheme 4). The yields of 10-12 were obtained under nonoptimized conditions. 
Scheme 4
Saponification of diastereoisomerically pure diesters 9-12 afforded the diacids 13-16 in quantitative yields. However, isomerization took place during saponification of the esters 9-11, and the antidiacids 13-15 were contaminated with ca. 10 % of the corresponding syn-diacids 17-19. Only diacid 16 was obtained as an isomerically pure compound. The crude diacids were used for the subsequent acetalization of pivaldehyde. This reaction was best achieved in benzene, affording the cis-dioxolanones 20-23 and the trans-dioxolanones 24-27 in a 5:1 ratio [20] . When diacids 13-15 were contaminated with the syn-isomers 17-19, dioxolanones 28-30 were obtained as a further by-product (ca. 10 %), whereas the fourth possible isomer having (2S,2′R,4′S)-configuration was not detected in any case. Isomerically pure dioxolanones 20-23 could be obtained from the crude reaction mixture after recrystallization. However, this process was not reliably reproducible and the yield for stereoisomerically pure 20 was low (50-70 %). Therefore, a mixture of the isomers was reacted with the benzyl bromides, in the presence of LHMDS at -78 °C. Surprisingly, only dioxolanones 20-23 were alkylated under these reaction conditions, providing isomerically pure dioxolanones 31-34 according to the 1 H NMR spectra of the crude reaction mixtures [19] . Dioxolanones 24-30 were recovered unchanged. The alkylation products 31-34 were isolated in 48-72 % yield. Selective reduction of the carboxy group with boranedimethylsulfide followed by acidic workup, produced the phenol-protected α-hydroxylated butyrolactone lignans. The solvent was critical in this reaction. When tetrahydrofuran (THF) was employed, over-reduction occurred. Thus, the reduction of 32 in THF furnished a mixture of lactone 35 (19 %) and lactol 36 (20 %). The reduction of 31, 33, and 34 was performed in ether. Yields of the corresponding lignans 37-39 were generally over 80 % in ether (Scheme 5). Hydrogenolysis of lactone lignan 37 afforded (-)-wikstromol (ent-3), and BBr 3 -mediated demethylation of 38 yielded lignan 40 (Scheme 6). (+)-Wikstromol (3) was obtained by the same method as described above, starting with R-diisopropyl malate.
BIOLOGICAL ACTIVITY OF THE SYNTHESIZED LACTONE LIGNANS
The inhibition of proliferation of HT29 colon cancer cells was investigated with the compounds shown in Scheme 6 in concentration ranges from 0.001 to 100 µM. In addition to both enantiomers of wikstromol, the "parent" lignans 35 and 36 were tested to quantify the effect of the carbonyl group. Lignan 39 was chosen because it was demonstrated in a previous study that its analog lacking the hydroxy group at C8 was highly active relative to other lignans, including enterolactone (2). Lignan 40, the hydroxylated analog of entereolactone (2) [21] , might be an important metabolite of wikstromol, in a relationship similar to that of matairesinol (1) and enterolactone (2) . Two HT29 cell lines were used (strain and clone 19a). Both cell lines were similarly inhibited by the lignans. The results of HT29 clone 19a are shown in Fig. 1 . As expected, the only active compound was lignan 39, having an IC 50 of ca. 35 µM.
In conclusion, the first efficient and enantioselective synthesis of α-hydroxylated lactone lignans has been demonstrated. Evaluation of the biological properties of these lignans revealed a non-natural derivative with relatively high cytotoxic activity. The synthesis of unsymmetrically substituted lactone lignans, as well as their biological activity with respect to other tumor cell lines, is currently underway. 
